Anna Lydon

1.5k citations
17 papers · 224 indexed · h-index 7
Topics
Prostate Cancer Treatment and Research (9 papers)Radiopharmaceutical Chemistry and Applications (5 papers)Cancer Treatment and Pharmacology (5 papers)

In The Last Decade

Anna Lydon

15 papers receiving 217 citations

Peers

Anna Lydon
Comparison fields: 5 of 48
  • Pulmonary and Respiratory Medicine 104
  • Oncology 76
  • Surgery 63
  • General Health Professions 38
  • Radiology, Nuclear Medicine and Imaging 32
Replace Shiva Dibaj with:
Shiva Dibaj United States
Zeynep Özsaran Türkiye
Sally S. Ingram United States
K. Spearman United States
Bridget L. Findlay United States
Angus Robinson United Kingdom
Charles L. Murray United States
Esaú Fernández‐Pascual Spain
Jeremy S. Slone United States
Claude Moreira Senegal
Anna Lydon relative to Shiva Dibaj United States Shiva Dibaj's profile →
Citations per field
00.5×3.5×
Shiva Dibaj · 1×
Citations per year

Countries citing papers authored by Anna Lydon

Since Specialization
Citations

This map shows the geographic impact of Anna Lydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lydon more than expected).

Fields of papers citing papers by Anna Lydon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lydon. The network helps show where Anna Lydon may publish in the future.

Co-authorship network of co-authors of Anna Lydon

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lydon. A scholar is included among the top collaborators of Anna Lydon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lydon. Anna Lydon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 59
5 2
6 5
7 22
8 4
9 29
10 6
11 5
12 13
13 6
14 5
15 1
16 2
17 63

About Anna Lydon

Anna Lydon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 224 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Urology (29 citations), Pulmonary and Respiratory Medicine (104 citations) and Oncology (76 citations). Anna Lydon has collaborated with scholars based in United Kingdom and Switzerland. Frequent co-authors include Keith Lloyd, Charles Montgomery, Nicholas D. James, Amit Bahl, James Wylie, Zafar Malik, Malcolm Crundwell, Peter Jenkins, Isabel Syndikus and Alison Birtle. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026